Michael R. Schlabach

8.0k total citations · 1 hit paper
27 papers, 3.8k citations indexed

About

Michael R. Schlabach is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Michael R. Schlabach has authored 27 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Oncology and 2 papers in Genetics. Recurrent topics in Michael R. Schlabach's work include CRISPR and Genetic Engineering (11 papers), DNA Repair Mechanisms (4 papers) and Epigenetics and DNA Methylation (3 papers). Michael R. Schlabach is often cited by papers focused on CRISPR and Genetic Engineering (11 papers), DNA Repair Mechanisms (4 papers) and Epigenetics and DNA Methylation (3 papers). Michael R. Schlabach collaborates with scholars based in United States, Switzerland and South Korea. Michael R. Schlabach's co-authors include Stephen J. Elledge, George W. Bates, Thomas F. Westbrook, Ji Luo, Gregory J. Hannon, Kwok‐Kin Wong, Chad J. Creighton, Michael J. Emanuele, Danan Li and Mamie Z. Li and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael R. Schlabach

27 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene

2009 779 citations Ji Luo, Michael J. Emanuele et al. Cell profile →

Peers

Countries citing papers authored by Michael R. Schlabach

Since Specialization

Citations

This map shows the geographic impact of Michael R. Schlabach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Schlabach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Schlabach more than expected).

Fields of papers citing papers by Michael R. Schlabach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Schlabach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Schlabach. The network helps show where Michael R. Schlabach may publish in the future.

Co-authorship network of co-authors of Michael R. Schlabach

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Schlabach. A scholar is included among the top collaborators of Michael R. Schlabach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Schlabach. Michael R. Schlabach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 2771: KSQ-4279 mediated USP1 inhibition induces replication associated DNA gaps that contribute to cell death 2023 ·Cancer Research ·(unknown), Pamela Sullivan, Yuji Mishina, Anne E. Dodson, (unknown), Hugh Gannon, Chris T. Middleton, Sol Shenker, (unknown), Michael R. Schlabach, Frank Stegmeier, Erica R. Tobin, (unknown), Andrew A. Wylie	1
2	204 KSQ-004: Unbiased pair-wise discovery of SOCS1 and Regnase-1 as the top CRISPR/Cas9 dual-edit combination enhancing in vivo TIL potency against solid tumors 2021 ·Regular and Young Investigator Award Abstracts ·Karrie Wong, (unknown), Sharon Lin, Isabelle Le Mercier, Caroline Bullock, (unknown), Anja Hohmann, Sol Shenker, (unknown), Leila J. Williams, Gregory V. Kryukov, (unknown), Frank Stegmeier, Micah J. Benson, Michael R. Schlabach	3
3	186 Development of KSQ-001, an engineered TIL (eTIL) therapy for solid tumors through CRISPR/Cas9-mediated editing of SOCS1 2021 ·SHILAP Revista de lepidopterología ·Karrie Wong, Sharon Lin, (unknown), (unknown), Leila J. Williams, (unknown), (unknown), Noah Tubo, Hugh Gannon, Robert A. LaMothe, Tianlei Xu, (unknown), Sol Shenker, Caroline Dugopolski, Frank Stegmeier, (unknown), Michael R. Schlabach, Micah J. Benson	1
4	Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers 2020 ·European Journal of Cancer ·(unknown), (unknown), Richard Sullivan, (unknown), Sol Shenker, Michael McGuire, Paula Grasberger, Kerstin W. Sinkevicius, Nafeeza Hafeez, Gavin Histen, Edmond Chipumuro, Julie A. Hixon, Elizabeth A. Krall, (unknown), Johannes H.W. de Wilt, Michael R. Schlabach, Frank Stegmeier, Andrew Olaharski, Andrew A. Wylie	15
5	Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss 2018 ·Nature Medicine ·Huayang Liu, Javad Golji, (unknown), Franklin Chung, Julie Chen, (unknown), Caroline Bullock, Michael D. Jones, Gráinne Kerr, Li Li, Daniel P. Rakiec, Michael R. Schlabach, Sosathya Sovath, Joseph D. Growney, Raymond Pagliarini, David A. Ruddy, Kenzie D. MacIsaac, Joshua M. Korn, E. Robert McDonald	221
6	Genetic interrogation of replicative senescence uncovers a dual role for USP28 in coordinating the p53 and GATA4 branches of the senescence program 2017 ·Genes & Development ·(unknown), Agata Smogorzewska, Chanhee Kang, Ji Luo, Michael R. Schlabach, Qikai Xu, (unknown), Stephen J. Elledge	28
7	A Chemical Genetics Approach for the Functional Assessment of Novel Cancer Genes 2015 ·Cancer Research ·Qianhe Zhou, Adnan Derti, David A. Ruddy, Daniel P. Rakiec, Iris Kao, (unknown), Veronica Gibaja, Homan Chan, Yi Yang, Junxia Min, Michael R. Schlabach, Frank Stegmeier	57
8	Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma 2014 ·Oncotarget ·Jie Li, Shan Zhu, David Kozono, Kimberly Ng, Diahnn Futalan, Ying Shen, Johnny Akers, Tyler Steed, Deepa Kushwaha, Michael R. Schlabach, Bob S. Carter, Chang‐Hyuk Kwon, Frank B. Furnari, Webster K. Cavenee, Stephen J. Elledge, Clark C. Chen	107
9	Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential 2012 ·Science ·Nicole L. Solimini, Qikai Xu, Craig H. Mermel, Anthony C. Liang, Michael R. Schlabach, Ji Luo, Anna E. Burrows, Anthony Anselmo, Andrea Bredemeyer, Mamie Z. Li, Rameen Beroukhim, Matthew Meyerson, Stephen J. Elledge	137
10	112 Genfome-wide shRNA Screening Defines the SUMO-activating Enzyme (SAE1/2) as a Novel Therapeutic Target for Tumors Driven by c-Myc Oncogenesis 2012 ·Neurosurgery ·Jessica D. Kessler, Kristopher T. Kahle, Tingting Sun, Kristen L. Meerbrey, Michael R. Schlabach, Earlene M. Schmitt, Samuel O. Skinner, Qinggang Xu, (unknown), Zachary C. Hartman, Mitchell Rao, Panpan Yu, Rocío Domínguez-Vidaña, Anthony C. Liang, Nicole L. Solimini, (unknown), (unknown), Tien Hsu, Ido Golding, Jianhua Luo	1
11	A Genetic Screen Identifies FAN1, a Fanconi Anemia-Associated Nuclease Necessary for DNA Interstrand Crosslink Repair 2010 ·Molecular Cell ·Agata Smogorzewska, Rohini Desetty, T. Saito, Michael R. Schlabach, Francis P. Lach, Mathew E. Sowa, Allan Clark, Thomas A. Kunkel, J. Wade Harper, Mónica P. Colaiácovo, Stephen J. Elledge	267
12	A Genome-wide Camptothecin Sensitivity Screen Identifies a Mammalian MMS22L-NFKBIL2 Complex Required for Genomic Stability 2010 ·Molecular Cell ·Brenda O’Connell, Britt Adamson, John R. Lydeard, Mathew E. Sowa, Alberto Ciccia, Andrea Bredemeyer, Michael R. Schlabach, Steven P. Gygi, Stephen J. Elledge, J. Wade Harper	90
13	A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene breakdown → 2009 ·Cell ·Ji Luo, Michael J. Emanuele, Danan Li, Chad J. Creighton, Michael R. Schlabach, Thomas F. Westbrook, Kwok‐Kin Wong, Stephen J. Elledge	779
14	Design of 240,000 orthogonal 25mer DNA barcode probes 2009 ·Proceedings of the National Academy of Sciences ·Qikai Xu, Michael R. Schlabach, Gregory J. Hannon, Stephen J. Elledge	116
15	Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening 2008 ·Science ·José M. Silva, Krista Marran, Joel S. Parker, Javier Silva, Michael C. Golding, Michael R. Schlabach, Stephen J. Elledge, Gregory J. Hannon, Kenneth Chang	225
16	Cancer Proliferation Gene Discovery Through Functional Genomics 2008 ·Science ·Michael R. Schlabach, Ji Luo, Nicole L. Solimini, Guang Hu, Qikai Xu, Mamie Z. Li, Zhenming Zhao, Agata Smogorzewska, Mathew E. Sowa, Xiaolu L. Ang, Thomas F. Westbrook, Anthony C. Liang, Kenneth Chang, (unknown), J. Wade Harper, Gregory J. Hannon, Stephen J. Elledge	291
17	A Genetic Screen for Candidate Tumor Suppressors Identifies REST 2005 ·Cell ·Thomas F. Westbrook, Eric S. Martin, Michael R. Schlabach, Yumei Leng, Anthony C. Liang, Bin Feng, Jean J. Zhao, Thomas M. Roberts, Gail Mandel, Gregory J. Hannon, Ronald A. DePinho, Lynda Chin, Stephen J. Elledge	390
18	Second-generation shRNA libraries covering the mouse and human genomes 2005 ·Nature Genetics ·José M. Silva, Mamie Z. Li, Ken C. N. Chang, Wei Ge, Michael C. Golding, Richard J. Rickles, Despina Siolas, Guang Hu, Patrick J. Paddison, Michael R. Schlabach, Nihar U. Sheth, Jeff Bradshaw, (unknown), Amit Kulkarni, Guy Cavet, Ravi Sachidanandam, W. Richard McCombie, Michele A. Cleary, Stephen J. Elledge, Gregory J. Hannon	491
19	Use of Denaturing HPLC to Provide Efficient Detection of Mutations Causing Familial Hypercholesterolemia 2002 ·Clinical Chemistry ·Olaf A. Bodamer, (unknown), Michael R. Schlabach, Christie M. Ballantyne, (unknown), Arthur L. Beaudet	26
20	THE SYNERGISTIC BINDING OF ANION AND FE3+ BY TRANSFERRIN 1975 ·Michael R. Schlabach, George W. Bates	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact